Share
Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480
ONCOTARGET
Gudernova, I; Balek, L; Varecha, M; Kucerova, JF; Bosakova, MK; Fafilek, B; Palusova, V; Uldrijan, S; Trantirek, L; Krejci, P, 2017: Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480. ONCOTARGET 8(65), p. 109319 - 109331, doi: 10.18632/oncotarget.22674
Research Groups:
CEITEC authors: